TABLE 5.

Adverse events reported by more than two subjects in any treatment group

Adverse eventaNo. (%) of subjects with adverse events receiving:
Low doseMedium doseHigh dose
Active (n = 14)Placebo (n = 14)Active (n = 7)Placebo (n = 7)Active (n = 14)Placebo (n = 14)
Total8 (57)8 (57)4 (57)3 (43)9 (64)5 (36)
Headache5 (36)2 (29)4 (57)2 (29)0 (0)1 (7)
Rash4 (29)1 (7)0 (0)0 (0)2 (14)0 (0)
Abnormal vision3 (21)3 (21)1 (7)2 (29)4 (29)1 (7)
Lab abnormalities1 (7)2 (14)1 (7)3 (43)4 (29)2 (14)
  • a All causalities.